Paradigm Clinical Research - San Diego — San Diego, California

Paradigm Clinical Research - San Diego is a clinical research site located in San Diego, California, United States 92108.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Paradigm Clinical Research - San Diego has participated in 4 clinical trials with 4 currently active.

Therapeutic areas: Alopecia Areata, Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases.

Sponsors: Sun Pharmaceutical Industries, Inc., Boehringer Ingelheim.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in San Diego

Browse all research sites in California · View every site in San Diego

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Paradigm Clinical Research - San Diego?

Paradigm Clinical Research - San Diego has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Paradigm Clinical Research - San Diego conducted?

Paradigm Clinical Research - San Diego has 4 clinical trials on record, with 4 currently active. Their work covers Alopecia Areata, Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases.

Is Paradigm Clinical Research - San Diego accredited by Crixeo Clinical Trials?

Paradigm Clinical Research - San Diego has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Paradigm Clinical Research - San Diego?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.